bioAffinity Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. 

CEO
Maria Zannes
CEOMaria Zannes
Employees
57
Employees57
Headquarters
San Antonio, Texas
HeadquartersSan Antonio, Texas
Founded
2014
Founded2014
Employees
57
Employees57

BIAF Key Statistics

Market cap
4.02M
Market cap4.02M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
—
Dividend yield—
Average volume
10.50M
Average volume10.50M
High today
$3.15
High today$3.15
Low today
$2.75
Low today$2.75
Open price
$2.78
Open price$2.78
Volume
1.29M
Volume1.29M
52 Week high
$67.12
52 Week high$67.12
52 Week low
$2.75
52 Week low$2.75
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.